Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ED.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCGEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.13.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBEEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.10.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.23.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.64EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.68EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.65 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.466EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
L.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.339EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.229EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.415EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.370EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.421EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.428.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.612EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.305EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JV.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used